新产品上线! Email验证工具 - 限时免费试用中立即试用

外贸营销群发邮件之前,先批量验证邮箱地址是否有效,可节省成本,提高发送成功率,减少被列入黑名单风险。 更多需求:邮箱采集/邮件群发

我如何向 ECHA 报告我已执行下游用户化学品安全报告(或我依赖豁免)?

问题(中文)
我如何向 ECHA 报告我已执行下游用户化学品安全报告(或我依赖豁免)?
Question (EN)
How do I report to ECHA that I have performed a downstream user chemical safety report (or I am relying on an exemption)?
中文内容由 Google Cloud Translation 自动生成,仅供参考;请以英文原文为准。问答资料来自欧盟化学品管理局(ECHA)官方网站。
答案(中文)
如果您需要编制下游用户化学品安全报告 (DU CSR) 或依赖第 37(4)(c) 或 (f) 条中的豁免,则必须向 ECHA 报告某些信息。纳米形态的下游用户可以通过 IUCLID 向 ECHA 报告信息,如《如何编制下游用户报告》手册中所述。报告包括以下必需信息(相应的 IUCLID 部分在括号中注明):下游用户的身份,即姓名、联系方式(REACH-IT 帐户和 IUCLID 第 1.1 节标识);物质的身份和纳米形态的特性,如 REACH 附件 VI 第 2.4 节所述(IUCLID 第 1.1 节标识和 1.2 节成分)供应商告知下游用户的注册号(IUCLID 第 1.3 节标识符);制造商、进口商或其他供应商的身份,即名称、联系方式(IUCLID 第 1.7 节“供应商”);使用地点(IUCLID 第 3.3 节“地点”);用途的简要描述(IUCLID 第 3.5 节“生命周期描述”),包括使用条件的信息;如果根据第 38(2)(f) 条适用,则建议对脊椎动物进行额外测试(IUCLID 第 5-7 节中的相关终点研究记录);报告类型的指示(包括所依赖的任何豁免),以及对需要报告的原因的解释,包括为什么无法通过供应商解决问题(IUCLID 第 14 节)。
Answer (EN)
If you need to prepare a downstream user chemical safety report (DU CSR) or you rely on the exemptions in Article 37(4)(c) or (f), then you must report certain information to ECHA. A downstream user of nanoforms can report information to ECHA via IUCLID, as described in the manual on How to prepare a downstream user report. The reporting comprises the following required information (the corresponding IUCLID section is indicated in brackets): Identity of the downstream user, i.e. name, contact details (REACH-IT account and IUCLID section 1.1 Identification); Identity of the substance and characterisation of the nanoform as specified in section 2.4 of Annex VI to REACH (IUCLID sections 1.1 Identification and 1.2 Composition) The registration number(s) as communicated to the downstream user by their suppliers (IUCLID section 1.3 Identifiers); Identity of the manufacturer(s), importer(s) or other supplier, i.e. name, contact details (IUCLID section 1.7 Suppliers); Site(s) of use (IUCLID section 3.3 Sites); A brief general description of the use(s) (IUCLID section 3.5 Life Cycle description) including the information on the conditions of use(s); If appropriate according to Article 38(2)(f), a proposal for additional testing on vertebrate animals (relevant endpoint study record(s) in IUCLID section 5-7); An indication of the type of report (including any exemptions relied upon), and an explanation for why the report was required, including why the issue could not be resolved through the supplier (IUCLID Section 14).